USA - NASDAQ:NBN - US66405S1006 - Common Stock
| TTM (2025-9-30) | 2025 (2025-6-30) | 2024 (2024-6-30) | 2023 (2023-6-30) | 2022 (2022-6-30) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 222.58M | 212.83M | 154.45M | 124.10M | 107.80M | |||
| Gross Premiums Earned | null | null | null | null | null | |||
| Loss Claims | null | null | null | null | null | |||
| Deferred Policy Acquisition Expense | null | null | null | null | null | |||
| Net Interest Income | 196.56M | 187.37M | 148.57M | 118.80M | 83.40M | |||
| Non Interest Income | 26.02M | 25.46M | 5.88M | 5.30M | 24.40M | |||
| Loan Loss Provision | 7.89M | 8.74M | 1.77M | 2.30M | -2.50M | |||
| Net Interest Income after Provision | 188.68M | 178.63M | 146.80M | 116.50M | 85.90M | |||
| Non Interest Expense | -82.59M | -78.39M | -64.57M | -56.50M | -48.80M | |||
| Minority Interest Expense | null | null | null | null | null | |||
| Cost Of Goods | null | null | null | null | null | |||
| Gross Profit | null | null | null | null | null | |||
| Operating Expenses | null | null | null | null | null | |||
| Research and Development | null | null | null | null | null | |||
| Selling, General, and Administrative Expenses | null | null | null | null | null | |||
| Operating Income | null | null | null | null | null | |||
| Interest Income/Expense | null | null | null | null | null | |||
| Other Income/Expense | null | null | null | null | null | |||
| Non Recurring Items | null | null | null | null | null | |||
| Income Before Taxes | 132.10M | 125.70M | 88.12M | 65.20M | 61.50M | |||
| Income Tax | 43.23M | 42.25M | 29.89M | 21.00M | 19.40M | |||
| Net Income | 88.88M | 83.44M | 58.23M | 44.20M | 42.20M | |||
| EBITDA | null | undefined | undefined | undefined | undefined | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 10.6337 | 10.0806 | 7.5831 | 5.96 | 5.34 | |||
| Non GAAP EPS | 10.64 | 10.08 | 7.6 | 5.96 | 5.33 | |||
| Statistics | ||||||||
| Profit Margin | 39.93% | 39.21% | 37.70% | 35.62% | 39.15% | |||
All data in USD